Figure 2From: Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy Methylation changes and cytoplasmic and nuclear CTR1 scores pre- and post-treatment. (a) Demethylation changes in blood. (b) Demethylation changes in tumor. (c) Cytoplasmic CTR1 score changes in tumor. (d) Nuclear CTR1 score changes in tumor.Back to article page